BUSINESS COMBINATIONS BUSINESS COMBINATIONS (Tables)

9 Months Ended

Jun. 28, 2019

The following table summarizes the estimated fair value of assets acquired and liabilities assumed as a result of the CTSI, Endocare and Alicon acquisitions:



(In millions)	CTSI			Endocare and Alicon
Assets acquired ⁽¹⁾	$	54.0		$	32.9
Liabilities assumed ⁽²⁾	(65.0		)	(17.7		)
Goodwill	182.1			122.7
Intangible assets	117.0			71.5
Fair value of net assets	288.1			209.4
Less: Non-controlling interest ⁽³⁾	8.8			—
Total purchase consideration	$	279.3		$	209.4

⁽¹⁾Includes $5.4 million and $11.5 million of cash and cash equivalents for CTSI and Endocare / Alicon, respectively.

⁽²⁾ Includes $33.9 million and $14.8 million of deferred tax liabilities for CTSI and Endocare / Alicon, respectively.

⁽³⁾The Company's non-controlling interest is a joint venture that was determined to be a variable interest entity. The Company has concluded that it is the primary beneficiary of the joint venture because it has the ability to control the significant activities of the joint venture, has the right to significant residual returns and is exposed to significant expected losses. The Company will consolidate the joint venture into its operations.

Valuation of Intangible Assets Acquired

The following table provides the valuation of the intangible assets acquired from CTSI, Endocare and Alicon, along with their estimated useful lives:



(Dollars in millions)	CTSI			Endocare and Alicon
Type	Fair Value		Weighted Average Estimated Useful Life (In Years)	Fair Value		Weighted Average Estimated Useful Life (In Years)
Technologies and trade names	$	47.9	10.7	$	56.3	7.7
Customer contracts, supplier relationships, and partner relationships ⁽¹⁾	69.1		26.4	4.8		3.0
Total intangible assets with finite lives	117.0			61.1
In-process research and development with indefinite lives	—			10.4
Total intangible assets	$	117.0		$	71.5

⁽¹⁾

CTSI has certain partner relationships with hospitals with useful lives that range from approximately 27 to 29 years.